[go: up one dir, main page]

RU2008112753A - METHOD FOR OBTAINING TUBERCULOSIS ANATOXIN - Google Patents

METHOD FOR OBTAINING TUBERCULOSIS ANATOXIN Download PDF

Info

Publication number
RU2008112753A
RU2008112753A RU2008112753/13A RU2008112753A RU2008112753A RU 2008112753 A RU2008112753 A RU 2008112753A RU 2008112753/13 A RU2008112753/13 A RU 2008112753/13A RU 2008112753 A RU2008112753 A RU 2008112753A RU 2008112753 A RU2008112753 A RU 2008112753A
Authority
RU
Russia
Prior art keywords
tuberculous
allergens
sorption
days
aluminum hydroxide
Prior art date
Application number
RU2008112753/13A
Other languages
Russian (ru)
Other versions
RU2392002C2 (en
Inventor
Анатолий Алексеевич Евглевский (RU)
Анатолий Алексеевич Евглевский
Владислав Михайлович Коломиец (RU)
Владислав Михайлович Коломиец
Дмитрий Анатольевич Евглевский (RU)
Дмитрий Анатольевич Евглевский
Елена Анатольевна Тимкова (RU)
Елена Анатольевна Тимкова
Светлана Юрьевна Епифанова (RU)
Светлана Юрьевна Епифанова
Original Assignee
ФГОУ ВПО Курская государственная сельскохозяйственная академия им. профессора И.И. Иванова (RU)
ФГОУ ВПО Курская государственная сельскохозяйственная академия им. профессора И.И. Иванова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ФГОУ ВПО Курская государственная сельскохозяйственная академия им. профессора И.И. Иванова (RU), ФГОУ ВПО Курская государственная сельскохозяйственная академия им. профессора И.И. Иванова filed Critical ФГОУ ВПО Курская государственная сельскохозяйственная академия им. профессора И.И. Иванова (RU)
Priority to RU2008112753/13A priority Critical patent/RU2392002C2/en
Publication of RU2008112753A publication Critical patent/RU2008112753A/en
Application granted granted Critical
Publication of RU2392002C2 publication Critical patent/RU2392002C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Способ получения туберкулезного анатоксина, включающий детоксикацию туберкулезных экзо- и эндотоксино-аллергенов раствором формалина, сорбцию на гидроксиде алюминия, стерилизацию, отличающийся тем, что детоксикацию 2,5±0,2 мг/мл туберкулезных токсино-аллергенов проводят двумя детоксикаторами - первоначально 0,2% раствором формалина в течение 7-9 сут при 42-45°С, а затем 0,5% раствором этония при 42-45°С в течение 7-9 сут, сорбцией на гидроксиде алюминия (1-3 мг/мл), а увеличение вдвое концентрации биопрепарата обеспечивают декантацией 50±5% надосадочной жидкости.A method for producing tuberculous toxoid, including detoxification of tuberculous exo and endotoxin allergens with formalin solution, sorption on aluminum hydroxide, sterilization, characterized in that detoxification of 2.5 ± 0.2 mg / ml tuberculous toxin allergens is carried out with two detoxifiers - initially 0, 2% formalin solution for 7-9 days at 42-45 ° C, and then a 0.5% ethonium solution at 42-45 ° C for 7-9 days, sorption on aluminum hydroxide (1-3 mg / ml) , and a doubling of the concentration of the biological product is provided by decantation of 50 ± 5% supernatant liquid.

Claims (1)

Способ получения туберкулезного анатоксина, включающий детоксикацию туберкулезных экзо- и эндотоксино-аллергенов раствором формалина, сорбцию на гидроксиде алюминия, стерилизацию, отличающийся тем, что детоксикацию 2,5±0,2 мг/мл туберкулезных токсино-аллергенов проводят двумя детоксикаторами - первоначально 0,2% раствором формалина в течение 7-9 сут при 42-45°С, а затем 0,5% раствором этония при 42-45°С в течение 7-9 сут, сорбцией на гидроксиде алюминия (1-3 мг/мл), а увеличение вдвое концентрации биопрепарата обеспечивают декантацией 50±5% надосадочной жидкости. A method for producing tuberculous toxoid, including detoxification of tuberculous exo and endotoxin allergens with formalin solution, sorption on aluminum hydroxide, sterilization, characterized in that detoxification of 2.5 ± 0.2 mg / ml tuberculous toxin allergens is carried out with two detoxifiers - initially 0, 2% formalin solution for 7-9 days at 42-45 ° C, and then a 0.5% ethonium solution at 42-45 ° C for 7-9 days, sorption on aluminum hydroxide (1-3 mg / ml) , and a doubling of the concentration of the biological product is provided by decantation of 50 ± 5% supernatant liquid.
RU2008112753/13A 2008-04-02 2008-04-02 Tuberculosis anatoxin manufacture method RU2392002C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008112753/13A RU2392002C2 (en) 2008-04-02 2008-04-02 Tuberculosis anatoxin manufacture method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008112753/13A RU2392002C2 (en) 2008-04-02 2008-04-02 Tuberculosis anatoxin manufacture method

Publications (2)

Publication Number Publication Date
RU2008112753A true RU2008112753A (en) 2009-10-10
RU2392002C2 RU2392002C2 (en) 2010-06-20

Family

ID=41260410

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008112753/13A RU2392002C2 (en) 2008-04-02 2008-04-02 Tuberculosis anatoxin manufacture method

Country Status (1)

Country Link
RU (1) RU2392002C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2631607C1 (en) * 2016-11-22 2017-09-25 Владислав Николаевич Ласкавый Means for cattle leukemia prevention and method for its application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504005A (en) * 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
RU2139090C1 (en) * 1999-01-26 1999-10-10 Закрытое акционерное общество "АгроБизнесЦентр" Method of preparing tuberculosis anatoxin
RU2170588C1 (en) * 2000-02-22 2001-07-20 Предприятие по производству бактерийных препаратов Научно-исследовательского института эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Method of preparing vaccine bcg-m for sparing primary immunization
RU2262950C2 (en) * 2001-03-23 2005-10-27 Каунсил Оф Сайентифик Энд Индастриал Рисерч Method for obtaining vaccine for treating tuberculosis and other intracellular infectious diseases and vaccine obtained according to declared method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2631607C1 (en) * 2016-11-22 2017-09-25 Владислав Николаевич Ласкавый Means for cattle leukemia prevention and method for its application

Also Published As

Publication number Publication date
RU2392002C2 (en) 2010-06-20

Similar Documents

Publication Publication Date Title
MX2013013111A (en) Multiple antigen presenting immunogenic composition, and methods and uses thereof.
GB201101665D0 (en) Immunogenic compositions
EA200801427A1 (en) ANTIBODY MOLECULES WITH SPECIFIC ACTIVITY WITH RESPECT TO HUMAN INTERLEUKIN-6 (IL-6)
NZ596599A (en) Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
WO2013006055A8 (en) A process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
MX2007012702A (en) Use of cd25 antibodies in immunotherapy.
WO2005103230A3 (en) Soy peptone as a nitrogen source in preparing meningococcal conjugates
MX2011009359A (en) Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions.
UA112747C2 (en) Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids
BR112013001168A2 (en) "toxoid, pharmaceutical composition, method of producing an antitoxin, antitoxin, and methods of treating an intoxicated individual from toxin vaccination and treating an intoxicated mammal."
JP2013523886A5 (en)
RU2008112753A (en) METHOD FOR OBTAINING TUBERCULOSIS ANATOXIN
MX2010009640A (en) Use of interleukin-1 conjugates in the treatment of diabetes.
PL386175A1 (en) New strains of bacteriophages for treatment of bacterial infections, preferably by means of the strains of drug-resistant bacterias of the Enterococcus type
WO2012106251A3 (en) Pertussis vaccine
TW200801180A (en) Vegetarian protein a preparation and methods thereof
RU2008113403A (en) DRUG FOR PROCESSING ORGANIC WASTE "ECOS"
RU2008115050A (en) METHOD FOR OBTAINING A STAFLOCOCCUS ANATOXIN-VACCINE
RU2010125576A (en) METHOD FOR OBTAINING AUTOBROBIOTICS CONTAINING LIVING BIFIDOBACTERIA AND LACTOBACILLI
BRPI0516372A (en) multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
BR0311463A (en) Compositions comprising a dietzia bacterium that are useful for the treatment of paratuberculosis in ruminants and a method for culturing the bacterium.
RU2008112803A (en) METHOD FOR PRODUCING SALMONELLOSE ANATOXIN-VACCINE
AR067085A1 (en) HOMOGENOUS VACCINE COMPOSITION FOR THE TREATMENT OF CANCER AND ITS METHOD OF OBTAINING
RU2008115049A (en) METHOD FOR PRODUCING STAFILO-STREPTOCOCCA ANATOXIN-VACCINE
TW200637907A (en) Novel vaccine for fish diseases against strepcococcemia

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110403